Varissara Sinkajarern

Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial

A. Kicic, A. Reiersen, P. Ounjai, 2024, EClinicalMedicine.